Clinical trial
Effect of Local Injectable Ropivacaine, Epinephrine, Clonidine, and Ketorolac (RECK) Anesthetic Cocktail on Postoperative Pain in Posterior Spinal Fusion
NCT06447194 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Local Injectable Ropivacaine, Epinephrine, Clonidine, and Ketorolac (RECK) Anesthetic Cocktail on Postoperative Pain in Posterior Spinal Fusion
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- October 1, 2025
- Completion date
- April 1, 2027
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease, degenerative disease, degenerative lumbar spinal stenosis, degenerative spondylolisthesis